Norwegian version of this page

NCMM Research Groups

The Centre for Molecular Medicine Norway consists of several research groups, lead by internationally recruited team leaders.

Group photo of the NCMM group leaders. From left to right: Emma Haapaniemi, Nikolina Sekulic, Marieke Kuijjer, Anthony Mathelier, Janna Saarela, Camila Esguerra, Sebastian Waszak, Charlotte Boccara, Irep Gozen and Judith Staerk

NCMM's group leaders in the Summer of 2022. From left to right: Emma Haapaniemi, Nikolina Sekulic, Marieke Kuijjer, Anthony Mathelier, Janna Saarela, Camila Esguerra, Sebastian Waszak, Charlotte Boccara, Irep Gozen and Judith Staerk. Photo: Oda Hveem/Visuello

Esguerra Group

Our research team is focused on exploring the fundamental mechanisms underlying brain function in health and disease.

Gözen Group

In our laboratory we use soft biomaterials, such as lipid membranes, to mimic the behavior of living cells.

Haapaniemi Group

Our group focuses on developing targeted therapies for rare immunological conditions, such as primary immunodeficiency diseases and immunological conditions of unknown origin.

Kuijjer Group

Our group aims to solve fundamental biological questions through the development of new methods in computational and systems biology.

Boccara Group

The Boccara group mission is to conduct innovative research projects at the junction of developmental neurobiology, system neuroscience and sleep research.

Sekulic Group

Our research group is using modern biophysical methods in combination with structural - and cell biology to answer important questions in the field of chromatin biology.

Mathelier Group

We aim to develop cutting-edge bioinformatics tools with immediate application to real-life biological problems, such as gene expression regulation and cancer.

Saarela Group

Our research focuses on improving the understanding of biological pathways and pathogenic mechanisms behind rare and common immune diseases, especially primary immune deficiencies and multiple sclerosis, and utilizing the new knowledge to benefit patients.

Sahu Group

Our goal is precision targeting of malfunctioning gene regulatory elements in human cancer and other enhanceropathies.

Waszak Group

Our group is working towards the development of precision medicine strategies for pediatric brain cancer patients.